No Detail Found!

Comparison of hypertonic saline and salbutamol nebulization in children with acute bronchiolitis in a tertiary care hospital

Author(s)
LUTFULLAH GOHEER Department of Pediatrics, CMH, Multan, Pakistan
ASAD MAQBOOL AHMED Department of Pediatrics, CMH, Multan, Pakistan
MUHAMMAD TARIQ NADEEM Department of Pediatrics, CMH, Rawalpindi, Pakistan
Zia ul Haq Department of Pediatrics, CMH, Multan, Pakistan
Saeed Zaman Khattak Department of Pediatrics, CMH, Rawalpindi, Pakistan
Junaid Bashir Department of Pediatrics, CMH, Multan, Pakistan
Abstract
Objective: To compare the duration of hospital stay with 3% hypertonic saline (HS) and salbutamol nebulization in children with acute bronchiolitis. Study Design: Randomized controlled trial. Place and Duration of Study: Department of Pediatrics, CMH Multan from 5th October 2020 to 5th April 2021. Material and Methods: The study comprised a total of 60 bronchiolitis patients of both sexs. Children were divided into Group A and B. Group A received nebulized 3 percent HS (4 ml) at an oxygen flow rate of 8 L/min, whereas those in Group B received nebulized salbutamol at a dose of 0.15 mg/kg body weight (minimum dose 1 mg) in normal saline at an oxygen flow rate of 8 L/min. Results: The age range in this study was between 1 month and 2 years, with group A's mean age being 14.366±4.31 months and group B's mean age being 15.800 ±4.15 months. In group A, the average length of stay was 3.533 days; in group B, it was 4.266 days (p=0.000). Conclusion: Nebulizing with 3 % HS is an efficient and secure treatment for moderately unwell, nonasthmatic individuals with acute bronchiolitis. Compared to salbutamol nebulization, HS dramatically reduces the CS scores and length of hospital stay.
Publication Details
Page(s) 387-391
DOI DOI not available
Published Journal: Pakistan Paediatric Journal, Volume: 47, Issue: 4, Year: 2023

Request the full text from PASTIC

Keywords
Children, Bronchiolitis
0

Citations

0

Downloads

137

Views